New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community.
—Los Angeles Times, September 2015
Discover the latest research into the benefits and risks of psychedelics and marijuana for psychotherapy, neuroscience, spirituality, and creativity, and more.
The Three-Day Conference (April 21-23) will feature three simultaneous tracks of presentations by leading and up-and-coming international researchers in the multidisciplinary field of psychedelic science and medicine. Presenters from around the world will share recently completed and ongoing research into the therapeutic, scientific, and spiritual uses of:
|...and much more!|
Clinical Research Track
Rick Doblin, Ph.D.
The Future of Psychedelic Therapy
Roland Griffiths, Ph.D.
Overview of the Johns Hopkins Psilocybin Research Project
Stan Grof, M.D.
Past and Future of Psychedelic Therapy
Breakthroughs in Psychedelic Research from the Beckley Foundation
Matthew Johnson, Ph.D.
Psychedelics as Behavior Change Agents: Addiction Recovery and Beyond
David Nichols, Ph.D.
David Nutt, M.D.
Psychedelic Research at the Beckley/Imperial Research Programme
Eduardo Schenberg, Ph.D.
Bringing MDMA-Assisted Psychotherapy to Brazil
Interdisciplinary Research Track
Erika Dyck, Ph.D.
Who is Keeping Tabs? LSD Lessons from the Past
James Fadiman, Ph.D., and Sophia Korb, Ph.D.
Preliminary Results from Psychedelic Microdosing Study
The Placebo Paradox
Ethan Nadelmann, Ph.D.
Drug Policy and Psychedelics
Claudio Naranjo, M.D.
Plant Medicine Track
Organized by Bia Labate, Ph.D.
Draulio Barros de Araujo, Ph.D.
On the Acute, Subacute and Antidepressant Effects of Ayahuasca
Christina Callicott, M.A.
Ethnomedicine Among the Lamista Quechua: History, Innovation and Cultural Revitalization
José Carlos Bouso, Ph.D.
What Do the Spirits Do? Towards an Understanding of the Psychological Mechanisms of Transformation
Clancy Cavnar, Psy.D.
An Examination of Psychological Healing with Ayahuasca
Wendy Chapkis, Ph.D.
Medical Marijuana in a Recreational Age
Alexander Dawson, Ph.D.
Peyote's Race Problem
Benjamin De Loenen, M.A.
Ayahuasca Legal Prosecution Worldwide: Connecting the Dots
Luís Fernando Tófoli, Ph.D.
Treating Alcohol-Related Disorders with Ayahuasca
Martin Fortier, Ph.D. Candidate
The Sense of Reality in Hallucinogenic Experiences: A Comparative Study of Serotoninergic and Anti-Cholinergic Plants
Alex K. Gearin, Ph.D.
Ayahuasca and the “Diet”: Some Cross-Cultural Considerations
Paul Glue, M.D., FRC Psych
Ibogaine and Opioid Withdrawal: Does it Work and Is it Safe?
J. Hamilton Hudson, J.D.
Bubbling with Controversy: Legal Issues of Ayahuasca Churches in the USA
O. Hayden Griffin, III, Ph.D.
The Therapeutic Potential of Kratom
Thomas Kingsley Brown, Ph.D.
Examining the Psyche in Psychedelic Treatment for Addiction
Anja Loizaga-Velder, Ph.D.
Evaluating the Efficacy of Ayahuasca Assisted Treatment for Substance Dependency
Diana Negrín, Ph.D.
Peyote Dreams: From Collective Ritual to Personal Treatment?
Raven Renèe Ray, M.A.
Ayahuasca Treatment Center Safety for the Western Seeker
Bruno Rasmussen Chaves, M.D.
Ibogaine in Brazil: Finally Stepping out from the Underground?
Amanda Reiman, Ph.D.
The Use of Cannabis as a Substitute for Opiate and Non-Opiate Based Pain Medication
Sidarta Ribeiro, Ph.D.
Whole Organisms or Pure Compounds? Entourage Effect versus Drug Specificity
Healing Encounters: Ayahuasca and the Politics of Knowledge
Constanza Sánchez Avilés, Ph.D.
Ayahuasca Practices as Intangible Cultural Heritage: A New Piece in the Drug Policy Puzzle?
Stacy B. Schaefer, Ph.D.
Peyote: Plant Medicine for the Body, Mind, and Soul
Scott Shannon, M.D., ABIHM
Cannabidiol in the Treatment of Anxiety: A Large Case Series
Jordan Sloshower, M.D.
Integrating Plant Medicines and Psychiatry: Theory and Methods of a Model Clinic
Graham St. John, Ph.D.
DMT, Liminality, and Hyperspace